Delivery Order SPE2DB20D2104-SPE2DB22FQ87Y
- Not listed
- This federal contract award, valued at $4,469.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award, valued at $1,015.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of June 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award, valued at $4,641.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,999.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for diabetes management. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $6,176.99. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $1,592.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage type 2 diabetes. The contract has a completion date of May 3, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, solicited by the Defense Logistics Agency (DLA), was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,738.42 firm fixed-price delivery order covers the procurement of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,464.08 Firm Fixed Price Delivery Order is for the supply of 0.75 mg/0.5 ml Trulicity Pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $14,198.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Trulicity 0.75 mg/0.5 ml pens, a pharmaceutical product used for diabetes management. Amerisourcebergen, a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award, valued at $2,390.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FQ87YDelivery Order
This federal contract award, valued at $4,653.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/1/21 |